NasdaqGM:TVTXBiotechs
Assessing Travere Therapeutics (TVTX) Valuation After Recent Share Price Weakness And FILSPARI Growth Hopes
Travere Therapeutics overview
Travere Therapeutics (TVTX) has drawn investor attention after recent trading, with the share price at $27.82 and mixed performance across different periods, including a negative move over the past 3 months but a positive 1 year total return.
See our latest analysis for Travere Therapeutics.
The recent 1 day share price return of negative 9.09% extends a weaker short term trend, with the 90 day share price return at negative 19.36%, even though the 1 year total...